Prostate, benign (hyperplasia BHP):

Men who have BPH with symptoms
usually need some kind of treatment at
some time. However, a number of
researchers have questioned the need
for early treatment when the gland is
just mildly enlarged. The results of
their studies indicate that early
treatment may not be needed because
the symptoms of BPH clear up without
treatment in as many as one-third of all
mild cases. Instead of immediate
treatment, they suggest regular
checkups to watch for early problems.
Over the years the FDA has approved
six drugs to relieve common symptoms
associated with an enlarged prostate.


GREEN LIGHT LASER FOR BENIGN
PROSTATIC HYPERPLASIA
GreenLight laser treatment of the
prostate is the newest, minimally
invasive surgical technique for
combating benign prostatic
hyperplasia (BPH). Performed with a
remarkable GreenLight Laser System,
photoselective vaporization can free
patients from the urinary problems
associated with BPH without
compromising their lifestyle or health.
PVP (photoselective vaporization of
the prostate) offers patients both the
immediate symptom relief and the
dramatic flow improvements of the
popular standard procedure known as
transurethral resection of the prostate
(or TURP) and the fast operative and
recovery times, minimal side effects
and catheter-free post op of other
minimally invasive techniques.
Photoselective prostate vaporization is
performed, using a specially designed
green-laser light source and fiber optic
delivery system, in an outpatient
setting, usually a surgical center or
hospital.
During the procedure, the GreenLight
laser surgical system, delivers laser
light pulses via a specially designed
fiber optic device inserted through a
standard cystoscope. The laser light
pulses are then directed toward the
enlarged prostate tissues. The green-
laser quickly and accurately vaporizes
the prostatic obstruction – removing
the enlarged portions of the prostate
without causing significant bleeding.
The average operative time is typically
under sixty-minutes and once the
procedure has been completed, most
patients experience immediate
symptom relief. More importantly,
studies have indicated that those
dramatic symptomological
improvements are durable, for
approximately a five-year follow-on
period.